We use cookies to provide you with the best possible experience. They also allow us to analyze user behavior in order to constantly improve the website for you. Privacy Policy
Key figures of the Group |
2020 | 20211 | 20222 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Sales | € million | 3,520 | 3,826 | 4,618 | 4,730 | 4,999 |
| EBITDA | € million | 742 | 814 | 922 | 9033 | 1,033 |
| EBITDA margin | in % | 21.1 | 21.3 | 20.0 | 19.13 | 20.7 |
| EBIT | € million | 488 | 559 | 630 | 6113 | 718 |
| EBIT margin | in % | 13.8 | 14.6 | 13.6 | 12.93 | 14.4 |
| Net income | € million | 307 | 375 | 406 | 340 | 478 |
| Balance sheet total (as of December 31) | € million | 5,940 | 6,673 | 7,783 | 7,846 | 8,325 |
| Capital ratio (as of December 31) | in % | 39.8 | 48.7 | 46.4 | 47.0 | 48.3 |
| Investments (without M&A) | € million | 159 | 174 | 270 | 270 | 231 |
| Net debt (incl. pension provisions and similar obligations (as of December 31)) | € million | 2,029 | 1,964 | 2,692 | 2,666 | 2,343 |
| Research and development expenses | € million | 212 | 221 | 254 | 266 | 276 |
| Operating cash flow | € million | 636 | 522 | 360 | 720 | 895 |
| Capital market | ||||||
| Shares issued as of balance sheet date | millions | 135.4 | 139.8 | 139.8 | 139.8 | 139.8 |
| Share price at end of fiscal year (Xetra® closing price) | in € | 108.4 | 130.3 | 101.7 | 99.6 | 102.7 |
| Market capitalization at end of fiscal year | € million | 14,680 | 18,212 | 14,208 | 13,927 | 14,350 |
| Earnings per share | in € | 2.27 | 2.74 | 2.91 | 2.44 | 3.42 |
| Dividend per share | in € | 0.97 | 1.02 | 1.05 | 1.10 | 1.204 |
1
Figures adjusted for the final purchase price allocation for Giraffe Foods
2
Excluding impairment of the associated company Swedencare
3
Adjusted for one-time effects
4
Proposal
| Our five goal dimensions | 2022 | 2023 | 2024 | Goal 2025 | |
|---|---|---|---|---|---|
| Business | |||||
| Organic sales growth | in % | 11.4 | 7.9 | 8.7 | 5.0 –7.0 (CAGR)7 |
| EBITDA margin1 | in % | 20.0 | 19.1 | 20.7 | ~ 21 |
| Footprint (environment) | |||||
| Improvement in eco-efficiency of greenhouse gas emissions (Scope 1+2)2 | in % | 10.4 | 4.4 | 9.4 | 6.6 p.a. |
| Reduction in absolute greenhouse gas emissions (Scope 3) | in % | 6.6 | 2.4 | – 15.3 | 3.0 p.a. |
| Improvement in eco-efficiency of chemical oxygen demand in wastewater2 | in % | 11.2 | 10.7 | 3.3 | 4.0 p.a. |
| Improvement in eco-efficiency of hazardous waste2 | in % | 3.8 | –6.3 | 3.0 | 4.0 p.a. |
| Water use3 | in % | –4.3 | –30.9 | 15.0 | –3.0 p.a. |
| Innovation | |||||
| Sales with new product developments4 | in % | 15.1 | 15.0 | 15.0 | ≥ 15.0 |
| Sourcing | |||||
| Suppliers rated according to sustainability criteria | in % | 875 | 1008 | 1008 | 100 |
| Sustainable sourcing of strategic biological raw materials | in % | 88 | 95 | 92 | 100 |
| Care (employees) | |||||
| Women in the first management level | in % | 16.0 | 13.5 | 23.0 | 30.0 |
| Women in the second management level | in % | 37.0 | 37.9 | 44.0 | 45.0 |
| Accident frequency | MAQ | 2.86 | 2.3 | 1.5 | < 1.5 |
1
2022 excluding impairment of the associated company Swedencare; 2023 adjusted for one-time effects
2
All figures relative to the value added
3
At production sites in regions with water stress (= Egypt, India, Mexico, Spain, Chile)
4
Relative to market launch in the past three years
5
Based on 80% (until 2021) or 90% (from 2022) of the procurement volume
6
MAQ = work accidents (>1 lost day) x 1 million/working hours; industry-leading occupational safety as of 2025
7
CAGR: compound annual growth rate
8
Based on the German Supply Chain Due Diligence Act (LkSG),
all suppliers were subjected to a risk assessment